U of I alumnus invents hepatitis C treatment
Michael Sofia ('84 PhD, Chemistry) developed sofosbuvir, which was just approved by the Food and Drug Administration to treat hepatitis C.
A University of Illinois alumnus has developed a drug to fight hepatitis C. Michael Sofia, a 1984 graduate with a PhD in Chemistry, works for Pharmasset, a small biotech company in New Jersey, and created the drug which manages the symptoms of hepatitis C. It's extrememly complicated to treat hepatitis C, a liver disease, because it is difficult to get the cells of the drug to enter the liver cells. Thankfully for the estimated 150 million people worldwide living with hepatitis C, Sofia was able to use the knowledge he learned from the U of I to invent this life changing drug. Read Michael Sofia's story about sofosbuvir at The New Yorker.
Share this story with other alumni and friends
The University of Illinois Alumni Association is dedicated to connecting alumni and friends to positively impact the University of Illinois, its alumni, and its students. Visit http://uiaa.org/illinois/membership/make_gift.html and support our work in connecting one global alumni family.